Literature DB >> 15670178

Herpes zoster following cryosurgery.

Michael R Lee1, William Ryman.   

Abstract

A 56-year-old man developed reactivation of herpes zoster infection on his right forehead after treatment of several solar keratoses with cryosurgery. The rash was blistering and painful. Treatment with oral aciclovir was instituted and the lesions healed within 2 weeks. Known risk factors for reactivation include age and decreased immunity. Previous case reports have indicated trauma may be a risk factor in herpes zoster. We report a case of herpes zoster as a complication of cryosurgery.

Entities:  

Mesh：

Year:  2005        PMID： 15670178     DOI： 10.1111/j.1440-0960.2005.00136.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


  4 in total

1.  Two cases of herpes zoster appearing after botulinum toxin type a injections.

Authors:  Emmy M Graber; Jeffrey S Dover; Kenneth A Arndt
Journal:  J Clin Aesthet Dermatol       Date:  2011-10

2.  Reactivation of herpes zoster along the trigeminal nerve with intractable pain after facial trauma: a case report and literature review.

Authors:  K-C Lin; Che-Chuan Wang; Kai-Yuan Wang; Yi-Chen Liao; Jinn-Rung Kuo
Journal:  BMJ Case Rep       Date:  2009-04-28

Review 3.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

4.  Late onset DCR surgical site herpes zoster in an immunocompetent patient: A rare presentation.

Authors:  E Vivek Chaitanya; T V Shruthi; Neeraj A Shah
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.